BlueCatBio
Private Company
Total funding raised: $18.2M
Overview
BlueCatBio is a private, revenue-generating tools and platform company that has established its Blue® Washer as a new standard for liquid handling in cell-based assays and genomics. Its core technology platform, centered on centrifugal evacuation, enables superior cell retention, reduced variability, and significant savings in consumables (tips) and time for customers in drug discovery and clinical diagnostics. The company is expanding its modular automation platform (Blue®CatX) and has a growing product portfolio targeting high-growth applications in cell therapy, flow cytometry, and next-generation sequencing. Its primary business model is the sale of instruments, accessories, and associated platforms to research and industrial labs.
Technology Platform
Centrifugal evacuation technology for contamination-free liquid removal from microtiter plates. Platform includes modular automation (Blue®CatX) combining centrifugation, evacuation, and dispensing for cell-based assays, magnetic bead separations, and genomics workflows.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes directly with large, diversified life science tools companies (e.g., Beckman Coulter, Tecan, PerkinElmer) that offer integrated liquid handling and automation systems. Also faces competition from other specialty liquid handling and plate washer companies. Differentiates through its unique centrifugal evacuation technology, which offers demonstrable advantages in cell retention and consumable savings for specific high-value applications.